Log in
Enquire now
‌

US Patent 9326991 Nucleotide prodrug compounds and use

Patent 9326991 was granted and assigned to Ligand Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Ligand Pharmaceuticals
Ligand Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
93269910
Patent Inventor Names
K. Raja Reddy0
Lin Zhi0
Date of Patent
May 3, 2016
0
Patent Application Number
144281510
Date Filed
September 12, 2013
0
Patent Citations Received
‌
US Patent 11970482 Acetal compounds and therapeutic uses thereof
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0
Patent abstract

Embodiments of the present invention include nucleoside 5′-monophosphate derivative compounds, their preparation and their uses. In some embodiments, nucleoside 5′-monophosphate derivative compounds are useful to treat viral infections.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9326991 Nucleotide prodrug compounds and use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.